Browse > Article
http://dx.doi.org/10.4046/trd.2009.67.1.47

Secondary Adrenal Insufficiency Associated with Megestrol Acetate in a Patient with Lung Cancer  

Park, Ji Chan (Department of Internal Medicine, The Catholic University of Korea College of Medicine)
Park, Suk Young (Department of Internal Medicine, The Catholic University of Korea College of Medicine)
Publication Information
Tuberculosis and Respiratory Diseases / v.67, no.1, 2009 , pp. 47-51 More about this Journal
Abstract
Loss of appetite is an important factor in the quality of life for advanced cancer patients. Megestrol acetate is used to stimulate appetite, but it can cause suppression of the pituitary adrenal axis due to the affinity of the glucocorticoid receptor. Adrenal insufficiency is a life threatening disorder if left, untreated, but the initial clinical symptoms of the patients are vague. Awareness of the glucocorticoid-like activity of megestrol acetate and its side effects are important for the diagnosis of adrenal insufficiency. We present a case of secondary adrenal insufficiency associated with megestrol acetate in a patient with lung cancer.
Keywords
Adrenal insufficiency; Lung neoplasms; Megestrol acetate;
Citations & Related Records

Times Cited By SCOPUS : 0
연도 인용수 순위
  • Reference
1 Mateen F, Jatoi A. Megestrol acetate for the palliation of anorexia in advanced, incurable cancer patients. Clin Nutr 2006;25:711-5   DOI   ScienceOn
2 Mann M, Koller E, Murgo A, Malozowski S, Bacsanyi J, Leinung M. Glucocorticoidlike activity of megestrol: a summary of food and drug administration experience and a review of the literature. Arch Intern Med 1997; 157:1651-6   DOI   ScienceOn
3 Chidakel AR, Zweig SB, Schlosser JR, Homel P, Schappert JW, Fleckman AM. High prevalence of adrenal suppression during acute illness in hospitalized patients receiving megestrol acetate. J Endocrinol Invest 2006; 29:136-40   DOI   PUBMED
4 Naing KK, Dewar JA, Leese GP. Megestrol acetate therapy and secondary adrenal suppression. Cancer 1999;86:1044-9   DOI   ScienceOn
5 Pascual Lopez A, Roqué i Figuls M, Urrutia Cuchi G, Berenstein EG, Almenar Pasies B, Balcells Alegre M, et al. Systematic review of megestrol acetate in the treatment of anorexia-cachexia syndrome. J Pain Symptom Manage 2004;27:360-9   DOI   ScienceOn
6 Salvatori R. Adrenal insufficiency. JAMA 2005;294:2481-8   DOI   PUBMED   ScienceOn
7 Ron IG, Soyfer V, Goldray D, Inbar MJ, Weisman Y. A low-dose adrenocorticotropin test reveals impaired adrenal function in cancer patients receiving megestrol acetate therapy. Eur J Cancer 2002;38:1490-4   DOI   ScienceOn
8 Kontula K, Paavonen T, Luukkainen T, Andersson LC. Binding of progestins to the glucocorticoid receptor: correlation to their glucocorticoid-like effects on in vitro functions of human mononuclear leukocytes. Biochem Pharmacol 1983;32:1511-8   DOI   ScienceOn
9 Raedler TJ, Jahn H, Goedeken B, Gescher DM, Kellner M, Wiedemann K. Acute effects of megestrol on the hypothalamic-pituitary-adrenal axis. Cancer Chemother Pharmacol 2003;52:482-6   DOI   ScienceOn
10 Loprinzi CL, Fonseca R, Jensen MD. Megestrol acetateinduced adrenal suppression. J Clin Oncol 1996;14:689   DOI   PUBMED